These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 32166907

  • 1. Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial.
    Dicembrini I, Pala L, Caliri M, Minardi S, Cosentino C, Monami M, Mannucci E.
    Diabetes Obes Metab; 2020 Aug; 22(8):1286-1291. PubMed ID: 32166907
    [Abstract] [Full Text] [Related]

  • 2. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures.
    Thomas MG, Avari P, Godsland IF, Lett AM, Reddy M, Oliver N.
    Diabetes Obes Metab; 2021 Nov; 23(11):2521-2528. PubMed ID: 34286892
    [Abstract] [Full Text] [Related]

  • 3. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH.
    Ann Intern Med; 2012 Sep 04; 157(5):336-47. PubMed ID: 22777524
    [Abstract] [Full Text] [Related]

  • 4. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I, Cosentino C, Monami M, Mannucci E, Pala L.
    Acta Diabetol; 2021 Apr 04; 58(4):401-410. PubMed ID: 32789691
    [Abstract] [Full Text] [Related]

  • 5. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Dicembrini I, Mannucci E, Monami M, Pala L.
    Diabetes Obes Metab; 2019 Dec 04; 21(12):2619-2625. PubMed ID: 31368658
    [Abstract] [Full Text] [Related]

  • 6. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R, Corro Ramos I, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, Duffy S, Worthy G, Al M, Severens J, Kleijnen J.
    Health Technol Assess; 2016 Feb 04; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [Abstract] [Full Text] [Related]

  • 7. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L, Dicembrini I, Mannucci E.
    Acta Diabetol; 2019 Sep 04; 56(9):973-980. PubMed ID: 30945047
    [Abstract] [Full Text] [Related]

  • 8. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
    Šoupal J, Petruželková L, Grunberger G, Hásková A, Flekač M, Matoulek M, Mikeš O, Pelcl T, Škrha J, Horová E, Škrha J, Parkin CG, Svačina Š, Prázný M.
    Diabetes Care; 2020 Jan 04; 43(1):37-43. PubMed ID: 31530663
    [Abstract] [Full Text] [Related]

  • 9. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW, Riddlesworth TD, Ruedy KJ, Kollman C, Ahmann AJ, Bergenstal RM, Bhargava A, Bode BW, Haller S, Kruger DF, McGill JB, Polonsky W, Price D, Toschi E, DIAMOND Study Group.
    Lancet Diabetes Endocrinol; 2017 Sep 04; 5(9):700-708. PubMed ID: 28711468
    [Abstract] [Full Text] [Related]

  • 10. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
    Ruiz-de-Adana MS, Dominguez-Lopez ME, Gonzalez-Molero I, Machado A, Martin V, Cardona I, de-la-Higuera M, Tapia MJ, Soriguer F, Anarte MT, Rojo-Martínez G.
    Med Clin (Barc); 2016 Mar 18; 146(6):239-46. PubMed ID: 26656958
    [Abstract] [Full Text] [Related]

  • 11. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G, Jiaqi L, Liyin Z, Jianan Y, Li F, Zhiyi D, Qin Z, Xia L, Lin Y, Zhiguang Z.
    Front Public Health; 2022 Mar 18; 10():990281. PubMed ID: 36091534
    [Abstract] [Full Text] [Related]

  • 12. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J, McKay A, Ridyard C, Thornborough K, Bedson E, Peak M, Didi M, Annan F, Gregory JW, Hughes D, Gamble C.
    Health Technol Assess; 2018 Aug 18; 22(42):1-112. PubMed ID: 30109847
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
    Wan W, Skandari MR, Minc A, Nathan AG, Zarei P, Winn AN, O'Grady M, Huang ES.
    Med Decis Making; 2018 Nov 18; 38(8):942-953. PubMed ID: 30403576
    [Abstract] [Full Text] [Related]

  • 14. RT-CGM in conjunction with CSII vs MDI in optimizing glycaemic control in T1DM: Systemic review and meta-analysis.
    William J, McCluskey J, Gleeson N.
    Endocrinol Diabetes Metab; 2022 Mar 18; 5(2):e00324. PubMed ID: 35118826
    [Abstract] [Full Text] [Related]

  • 15. Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study.
    Blevins T, Lane W, Rodbard D, Sindelar D, Fan L, Ellinor K, Ilag L, Ly T, Johnson J.
    Diabetes Technol Ther; 2021 Jan 18; 23(1):51-58. PubMed ID: 32631081
    [Abstract] [Full Text] [Related]

  • 16. Continuous Glucose Monitoring Use in Type 1 Diabetes: Longitudinal Analysis Demonstrates Meaningful Improvements in HbA1c and Reductions in Health Care Utilization.
    Parkin CG, Graham C, Smolskis J.
    J Diabetes Sci Technol; 2017 May 18; 11(3):522-528. PubMed ID: 28745091
    [Abstract] [Full Text] [Related]

  • 17. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R, Alsubaiee M, Alqarni A, Saleh Y, Aljaser S, Salam A, Eledrisi M.
    Diabetes Technol Ther; 2017 Jun 18; 19(6):349-354. PubMed ID: 28296467
    [Abstract] [Full Text] [Related]

  • 18. The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4).
    Seyed Ahmadi S, Westman K, Pivodic A, Ólafsdóttir AF, Dahlqvist S, Hirsch IB, Hellman J, Ekelund M, Heise T, Polonsky W, Wijkman M, Schwarcz E, Lind M.
    Diabetes Care; 2020 Sep 18; 43(9):2017-2024. PubMed ID: 32641374
    [Abstract] [Full Text] [Related]

  • 19. Continuous glucose monitoring systems for type 1 diabetes mellitus.
    Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ.
    Cochrane Database Syst Rev; 2012 Jan 18; 1(1):CD008101. PubMed ID: 22258980
    [Abstract] [Full Text] [Related]

  • 20. Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study.
    Grunberger G, Bhargava A, Ly T, Zisser H, Ilag LL, Malone J, Fan L, Zhang S, Johnson J.
    Diabetes Obes Metab; 2020 Mar 18; 22(3):434-441. PubMed ID: 31865633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.